BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26791159)

  • 1. Medical therapies for pulmonary arterial hypertension.
    Pulido T; Zayas N; de Mendieta MA; Plascencia K; Escobar J
    Heart Fail Rev; 2016 May; 21(3):273-83. PubMed ID: 26791159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Pulmonary Arterial Hypertension.
    Weatherald J; Varughese RA; Liu J; Humbert M
    Semin Respir Crit Care Med; 2023 Dec; 44(6):746-761. PubMed ID: 37369218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of pulmonary hypertension in children.
    Vorhies EE; Ivy DD
    Paediatr Drugs; 2014 Feb; 16(1):43-65. PubMed ID: 24114695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.
    Moutchia J; McClelland RL; Al-Naamani N; Appleby DH; Holmes JH; Minhas J; Mazurek JA; Palevsky HI; Ventetuolo CE; Kawut SM
    Eur Heart J; 2024 Jun; 45(21):1937-1952. PubMed ID: 38416633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Arterial Hypertension: Pathophysiology and Treatment.
    Lan NSH; Massam BD; Kulkarni SS; Lang CC
    Diseases; 2018 May; 6(2):. PubMed ID: 29772649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies.
    Rucker JA; Beinfeld MT; Enright DE; Germack HD; Panjabi S; Chakinala MM; Chambers JD
    J Manag Care Spec Pharm; 2024 Jun; 30(6):541-548. PubMed ID: 38824632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent strategies in treatment of pulmonary arterial hypertension, a review.
    Fallah F
    Glob J Health Sci; 2015 Jan; 7(4):307-22. PubMed ID: 25946920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical treatment update on pulmonary arterial hypertension.
    Enderby CY; Burger C
    Ther Adv Chronic Dis; 2015 Sep; 6(5):264-72. PubMed ID: 26336595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why patients who die of worsening pulmonary arterial hypertension are not on parenteral prostacyclin analog treatment?
    Tonelli AR; Dweik RA
    J Heart Lung Transplant; 2014 Feb; 33(2):221. PubMed ID: 24157181
    [No Abstract]   [Full Text] [Related]  

  • 10. Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension.
    Lange TJ
    Herz; 2023 Aug; 48(4):259-265. PubMed ID: 37085727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension.
    Auth R; Klinger JR
    Expert Opin Investig Drugs; 2023; 32(11):1025-1042. PubMed ID: 37881882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Targeted therapy for pulmonary arterial hypertension in patients without comorbidities].
    Klose H; Harbaum L; Richter MJ; Lichtblau M; Marra AM; Kabitz HJ; Harutyunova S; Milger-Kneidinger K; Lange TJ
    Pneumologie; 2023 Nov; 77(11):890-900. PubMed ID: 37963478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies.
    Rosanio S; Pelliccia F; Gaudio C; Greco C; Keylani AM; D'Agostino DC
    Biomed Res Int; 2014; 2014():743868. PubMed ID: 25013799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing of endothelin receptor antagonists and riociguat in women of childbearing age in a large German claims database study.
    Amann U; Nadine Wentzell ; Kollhorst B; Haug U
    Reprod Toxicol; 2023 Aug; 119():108415. PubMed ID: 37245698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
    Alamri AK; Ma CL; Ryan JJ
    Drugs; 2023 May; 83(7):577-585. PubMed ID: 37017914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities.
    Badlam JB; Bull TM
    Ther Adv Chronic Dis; 2017 Feb; 8(2-3):47-64. PubMed ID: 28348727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Treatment of Pulmonary Hypertension in Children.
    Avitabile CM; Vorhies EE; Ivy DD
    Paediatr Drugs; 2020 Apr; 22(2):123-147. PubMed ID: 31960361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives for the treatment of pulmonary hypertension.
    Baliga RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2011 May; 163(1):125-40. PubMed ID: 21175577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review.
    Xiao Y; Chen PP; Zhou RL; Zhang Y; Tian Z; Zhang SY
    Aging Dis; 2020 Dec; 11(6):1623-1639. PubMed ID: 33269111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying "super responders" in pulmonary arterial hypertension.
    Halliday SJ; Hemnes AR
    Pulm Circ; 2017; 7(2):300-311. PubMed ID: 28597766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.